Akili, Inc. (AKLI)

NASDAQ: AKLI · IEX Real-Time Price · USD
0.243
+0.009 (3.72%)
At close: Feb 20, 2024, 3:58 PM
0.248
+0.005 (2.22%)
After-hours: Feb 20, 2024, 6:35 PM EST
3.72%
Market Cap 19.01M
Revenue (ttm) 1.04M
Net Income (ttm) -65.16M
Shares Out 78.31M
EPS (ttm) -1.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 127,319
Open 0.245
Previous Close 0.234
Day's Range 0.221 - 0.250
52-Week Range 0.207 - 2.080
Beta 1.78
Analysts Buy
Price Target 4.00 (+1,548.13%)
Earnings Date Mar 5, 2024

About AKLI

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, ... [Read more]

Sector Healthcare
Founded 1997
Employees 66
Stock Exchange NASDAQ
Ticker Symbol AKLI
Full Company Profile

Financial Performance

In 2022, Akili's revenue was $323,000, a decrease of -39.96% compared to the previous year's $538,000. Losses were -$19.04 million, -84.97% less than in 2021.

Financial Statements

Analyst Forecast

According to one analyst, the rating for AKLI stock is "Buy" and the 12-month stock price forecast is $4.0.

Price Target
$4.0
(1,548.13% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Akili Reports Third Quarter 2023 Financial Results and Provides Business Update

BOSTON--(BUSINESS WIRE)--Akili Reports Third Quarter 2023 Financial Results and Provides Business Update.

3 months ago - Business Wire

Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ET

BOSTON--(BUSINESS WIRE)--Akili to Host Third Quarter Financial Results Conference Call on Thursday, November 9 at 4:30 p.m.

4 months ago - Business Wire

Employees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study Finds

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), the leading digital medicine company behind EndeavorOTC™, today released results from a new study examining the ways in which ADHD impacts the U.S....

4 months ago - Business Wire

Akili Announces Leadership Transition

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that Eddie Martucci transitioned to the role of Board chair, and Matt Franklin has been appoint...

4 months ago - Business Wire

Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD

BOSTON--(BUSINESS WIRE)--Akili Releases EndeavorOTC on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD.

5 months ago - Business Wire

Akili Announces Business Transformation, Focusing on Non-prescription Model

BOSTON--(BUSINESS WIRE)--Akili plans transition to non-Rx business, increasing patient access to clinically-proven non-drug treatments and reducing reliance on intermediaries.

5 months ago - Business Wire

Akili Reports Second Quarter 2023 Financial Results and Provides Business Update

BOSTON--(BUSINESS WIRE)--Akili Reports Second Quarter 2023 Financial Results and Provides Business Update.

6 months ago - Business Wire

Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ET

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its financial and operating results for the second quarter of...

8 months ago - Business Wire

Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD

BOSTON--(BUSINESS WIRE)---- $AKLI #ADHD--Adults with ADHD can now improve their attention & focus with a new clinically-proven mobile video game treatment. Available now in the iOS App Store.

9 months ago - Business Wire

Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych Congress

BOSTON--(BUSINESS WIRE)---- $AKLI #ADHD--Akili To Presents Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at Upcoming Scientific Meetings.

9 months ago - Business Wire

Akili Reports First Quarter 2023 Financial Results and Provides Business Update

BOSTON--(BUSINESS WIRE)---- $AKLI #ADHD--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter ended March 31, 2023, and provided an upda...

10 months ago - Business Wire

PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili's EndeavorRx® Video Game-Based Therapeutic

BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Akili Announces Topline Results of the STARS-ADHD-Adult Clinical Trial.

10 months ago - Business Wire

Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili's EndeavorRx® Video Game-Based Therapeutic

BOSTON--(BUSINESS WIRE)---- $AKLI #ADHD--Adults with ADHD improve their attention and quality of life using EndeavorRx video game treatment in clinical trial.

10 months ago - Business Wire

Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET

BOSTON--(BUSINESS WIRE)---- $AKLI #ADHD--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its financial and operating results for the f...

11 months ago - Business Wire

Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter and full year ended December 31, 2022, and provided an upd...

1 year ago - Business Wire

Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its financial and operating results for the fourth quarter ...

1 year ago - Business Wire

Akili to Participate in the Cowen 43rd Annual Health Care Conference

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Cowen 43rd Annual Health Care Conference in Boston next month.

1 year ago - Business Wire

Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Biotech Showcase and Solebury 1x1 Management Access Conference, both happening alongs...

1 year ago - Business Wire

Pivotal Trial of EndeavorRxⓇ in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced topline results of the STARS-ADHD-Adolescents label expansion study evaluating the efficacy a...

1 year ago - Business Wire

Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer

BOSTON--(BUSINESS WIRE)--Akili, Inc., a leading commercial digital medicine company, today announced the appointment of Scott Kollins, Ph.D., as chief medical officer, effective December 1, 2022. Dr...

1 year ago - Business Wire

Akili Reports Third Quarter 2022 Financial Results and Company Update

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter ended September 30, 2022, and provided an update on busi...

1 year ago - Business Wire

Financial Industry Veteran Mary Hentges Joins Akili's Board of Directors

BOSTON--(BUSINESS WIRE)--Akili, Inc. (NASDAQ: AKLI), a leading digital medicine company, today announced the appointment of Mary Hentges to the company's board of directors, effective October 25, 2022...

1 year ago - Business Wire

Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its third quarter financial results on Thursday, November 10,...

1 year ago - Business Wire

Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry

BOSTON--(BUSINESS WIRE)---- $AKLI--Akili Interactive (“Akili”), a leading digital medicine company, today announced the EndeavorRx® Expedition product registry, which aims to obtain feedback from pati...

1 year ago - Business Wire

Akili to Participate in LifeSci Partners HealthTech Symposium

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that management will present at a fireside chat and participate in a panel discussion on prescr...

1 year ago - Business Wire